$353.08
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Country

US

CEO

Mr. Eric Green

IPO date

1923

Employees

10,800

ISIN

US9553061055

Key stats

Open

$357.87

Volume

511.38K

Market cap

$23.90B

Prev. close

$353.08

Impl / hst vl

-

Open interest

$0.00

$349.70

Day’s Range

$359.18

$223.83

52W Range

$386.00

Valuation

55
Valuation score
Fairly Valued
P/E
43.89
P/S
7.45
P/B
8.29
Current ratio
2.82
Debt / Equity
0.07
ROE
18.51%
Gross margin
37.74%
Income growth
10.95%
FCF growth
71.19

Aug

5

Dividends

The last payment date was Aug 5, 2026

Div. per Share

$0.22

Div. Yield

0.06%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 14 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$405.03
The top 19 analysts forecasts that 12-month price may increase by 14.71%, with a low of $340.37 and a high of $481.95
$340.37
Low
$405.03
Avg
$481.95
High
Current price

Earnings

Q2 ‘26 revenue
$872.30M
Q2 ‘26 net income
$154.00M
Revenue
Net income
Previous EPS
$2.13
Estimate EPS
$2.10
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply